Papers Published

1. Roberts, MK; Fisher, DM; Parker, LE; Darnell, D; Sugarman, J; Carrithers, J; Weinfurt, K; Jurkovich, G; Zatzick, D, Ethical and Regulatory Concerns in Pragmatic Clinical Trial Monitoring and Oversight., Ethics Hum Res, vol. 42 no. 5 (September, 2020), pp. 29-37 [doi].
   (last updated on 2026/01/22)

   Abstract:
   The implementation of pragmatic clinical trials (PCTs) can be accompanied by unique regulatory challenges. In this paper, we describe the experience and management of regulatory noncompliance during a 25-site acute care PCT. During the trial, the study team conducted a comprehensive audit of all enrollment forms (informed consent and Health Insurance Portability and Accountability Act authorization forms) and related study documentation. A review of 997 participants' enrollment forms identified 138 (13.8%) that required reporting to the institutional review board due to noncompliance. To prevent subsequent noncompliance, the study team developed and introduced a revised participant tracking system, reviewed all enrollment documentation, and retrained sites regarding study procedures. Based on these experiences, we developed a set of recommendations for future PCTs to ensure both operational success and regulatory compliance.